Clinical Research

Clinical Research

Our Expertise Streamlines Your Product's Journey

We evaluate drugs for poisoning treatment applications and orphan drug indications that involve multi-center operations, study management, data collection, data management, data analysis and reporting.

We have helped several drug companies to develop antidotes for poisonings in the US, including:

CroFab − North American crotaline snake envenomation

DigiFab − cardiac glycoside intoxications

Antizol − toxic alcohol (methanol & ethylene glycol) intoxications

Acetadote – acetaminophen intoxications

Radiogardase − thallium and radiocesium exposures

Cyanokit − cyanide exposures

Study Design

Addressing research questions with protocol development outcomes, design and methodology development to illustrate drug safety and efficacy


Learn More

Clinical Trials Project Management

Planning, resourcing and risk management for Phase II - IV clinical trials


Learn More

Patient Enrollment

Providing a data-driven, patient-centric approach to operations related to recruitment, screening, engagement and retention


Learn More

Clinical Data Management

Offering data collection and analysis, biostatistics support, CRF development and database management


Learn More

Clinical Site Investigator Network

Supplying an expanded network of patients through decades of site network experience


Learn More

Clinical Trials Monitoring

Reviewing data collection and records to ensure data integrity and regulatory compliance


Learn More

Why Rocky Mountain?

With over 65 years of industry experience, Rocky Mountain Poison & Drug Safety is the leader in providing specialized services spanning the lifecycle of a drug or consumer product to public health, government agencies, and the pharmaceutical and consumer products industries.We ensure the highest level of service to our clients by meeting their unique and complex needs.